Study Evaluating Tarlatamab in Chinese Participants With Advanced Small Cell Lung Cancer After Two or More Prior Lines of Treatment | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study Evaluating Tarlatamab in Chinese Participants With Advanced Small Cell Lung Cancer After Two or More Prior Lines of Treatment	Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor	Active, not recruiting	Phase 2	2026-07-09		NCT06502977

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Amgen	180

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Army Special Medical Center of Peoples Liberation Army	Chongqing	China	2
Beijing Cancer Hospital	Beijing	China	208
Fujian Cancer Hospital	Fuzhou	China	4
Harbin Meidical University Cancer Hospital	Harbin	China	2
Jiangmen Central Hospital	Jiangmen	China	18
Mengchao Hepatobiliary Hospital of Fujian Medical University	Fuzhou	China	8
Sun Yat-sen University Cancer Center	Guangzhou	China	315
Taizhou Hospital Of Zhejiang Province	Linhai	China	5
The Second Affiliated Hospital of Army Medical University, People's Liberation Army	Chongqing	China	1
The Second Affiliated Hospital of Zhejiang University School of Medicine	Hangzhou	China	30
Tianjin Medical University General Hospital	Tianjin	China	61
Tongji Hospital Tongji Medical College Huazhong University of Science and Technology	Wuhan	China	3